Cargando…
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection
The oncoprotein Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) is overexpressed in most malignancies and is an obvious candidate target protein for future cancer therapies. However, the physiological importance of CIP2A-mediated PP2A inhibition is largely unknown. As PP2A regulates immune res...
Autores principales: | Côme, Christophe, Cvrljevic, Anna, Khan, Mohd Moin, Treise, Irina, Adler, Thure, Aguilar-Pimentel, Juan Antonio, Au-Yeung, Byron, Sittig, Eleonora, Laajala, Teemu Daniel, Chen, Yiling, Oeder, Sebastian, Calzada-Wack, Julia, Horsch, Marion, Aittokallio, Tero, Busch, Dirk H., Ollert, Markus W., Neff, Frauke, Beckers, Johannes, Gailus-Durner, Valerie, Fuchs, Helmut, de Angelis, Martin Hrabě, Chen, Zhi, Lahesmaa, Riitta, Westermarck, Jukka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839633/ https://www.ncbi.nlm.nih.gov/pubmed/27100879 http://dx.doi.org/10.1371/journal.pone.0152996 |
Ejemplares similares
-
Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling
por: Kauko, Otto, et al.
Publicado: (2015) -
Extensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression
por: Kaklamanos, Aimilios, et al.
Publicado: (2017) -
A practical comparison of methods for detecting transcription factor binding sites in ChIP-seq experiments
por: Laajala, Teemu D, et al.
Publicado: (2009) -
Probe-level estimation improves the detection of differential splicing in Affymetrix exon array studies
por: Laajala, Essi, et al.
Publicado: (2009) -
ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts
por: Laajala, Teemu D, et al.
Publicado: (2018)